Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 179

1.

Preoperative transarterial chemoembolization for hepatocellular carcinoma.

Kishi Y, Saiura A, Yamamoto J, Koga R, Seki M, Morimura R, Yoshioka R, Kokudo N, Yamaguchi T.

Hepatogastroenterology. 2012 Oct;59(119):2295-9. doi: 10.5754/hge10730.

PMID:
23435144
[PubMed - indexed for MEDLINE]
2.

The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.

Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M.

Cancer. 2000 Dec 15;89(12):2606-12.

PMID:
11135222
[PubMed - indexed for MEDLINE]
3.

Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.

Hsu KF, Chu CH, Chan DC, Yu JC, Shih ML, Hsieh HF, Hsieh TY, Yu CY, Hsieh CB.

Eur J Radiol. 2012 Mar;81(3):466-71. doi: 10.1016/j.ejrad.2010.12.058. Epub 2011 Mar 3.

PMID:
21376495
[PubMed - indexed for MEDLINE]
4.

Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma.

Kang JY, Choi MS, Kim SJ, Kil JS, Lee JH, Koh KC, Paik SW, Yoo BC.

Korean J Hepatol. 2010 Dec;16(4):383-8. doi: 10.3350/kjhep.2010.16.4.383.

PMID:
21415582
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Role of surgical resection for multiple hepatocellular carcinomas.

Choi SH, Choi GH, Kim SU, Park JY, Joo DJ, Ju MK, Kim MS, Choi JS, Han KH, Kim SI.

World J Gastroenterol. 2013 Jan 21;19(3):366-74. doi: 10.3748/wjg.v19.i3.366.

PMID:
23372359
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.

Lee KT, Lu YW, Wang SN, Chen HY, Chuang SC, Chang WT, Shi HY, Ker CG, Chiu HC.

J Surg Oncol. 2009 May 1;99(6):343-50. doi: 10.1002/jso.21248.

PMID:
19226530
[PubMed - indexed for MEDLINE]
7.

Preoperative transarterial chemoembolization and resection for hepatocellular carcinoma: a nationwide Taiwan database analysis of long-term outcome predictors.

Shi HY, Wang SN, Wang SC, Chuang SC, Chen CM, Lee KT.

J Surg Oncol. 2014 Apr;109(5):487-93. doi: 10.1002/jso.23521. Epub 2013 Nov 30.

PMID:
24293372
[PubMed - indexed for MEDLINE]
8.

The effect of postoperative TACE on prognosis of HCC with microscopic venous invasion.

Ke-Wei L, Tian-Fu W, Xi L, Lü-Nan Y, Bo L, Yong Z, Wu-Sheng L, Wen-Tao W, Ming-Qing X, Jia-Yin Y, Yu-Kui M, Zhe-Yu C.

Hepatogastroenterology. 2012 Sep;59(118):1944-6. doi: 10.5754/hge11845.

PMID:
22246191
[PubMed - indexed for MEDLINE]
9.

Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.

Kim JM, Kwon CH, Joh JW, Choi MS, Lee JH, Koh KC, Paik SW, Kim GS, Kim SJ, Lee SK, Yoo BC.

Transplant Proc. 2012 Mar;44(2):403-8. doi: 10.1016/j.transproceed.2012.01.067.

PMID:
22410028
[PubMed - indexed for MEDLINE]
10.

Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.

Kim IS, Lim YS, Lee HC, Suh DJ, Lee YJ, Lee SG.

Aliment Pharmacol Ther. 2008 Feb 15;27(4):338-45. Epub 2007 Nov 28.

PMID:
18047564
[PubMed - indexed for MEDLINE]
Free Article
11.

Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.

Takayasu K, Arii S, Ikai I, Kudo M, Matsuyama Y, Kojiro M, Makuuchi M; Liver Cancer Study Group of Japan.

AJR Am J Roentgenol. 2010 Mar;194(3):830-7. doi: 10.2214/AJR.09.3308.

PMID:
20173167
[PubMed - indexed for MEDLINE]
12.

Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.

Sasaki A, Iwashita Y, Shibata K, Ohta M, Kitano S, Mori M.

Eur J Surg Oncol. 2006 Sep;32(7):773-9. Epub 2006 Jun 21.

PMID:
16797156
[PubMed - indexed for MEDLINE]
13.

Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma.

Zhao WC, Zhang HB, Yang N, Fu Y, Qian W, Chen BD, Fan LF, Yang GS.

World J Gastroenterol. 2012 Jul 7;18(25):3272-81. doi: 10.3748/wjg.v18.i25.3272.

PMID:
22783052
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.

Huang J, Li BK, Chen GH, Li JQ, Zhang YQ, Li GH, Yuan YF.

J Gastrointest Surg. 2009 Sep;13(9):1627-35. doi: 10.1007/s11605-009-0933-4. Epub 2009 Jun 9.

PMID:
19506976
[PubMed - indexed for MEDLINE]
15.

Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.

Li M, Lu C, Cheng J, Zhang J, Cao C, Xu J, Xu J, Pan H, Zhong B, Tucker S, Wang D.

J Gastroenterol Hepatol. 2009 Aug;24(8):1437-44. doi: 10.1111/j.1440-1746.2009.05863.x. Epub 2009 May 28.

PMID:
19486255
[PubMed - indexed for MEDLINE]
16.

Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.

Xi T, Lai EC, Min AR, Shi LH, Wu D, Xue F, Wang K, Yan Z, Xia Y, Shen F, Lau WY, Wu MC.

Hepatogastroenterology. 2012 Jun;59(116):1198-203. doi: 10.5754/hge09654.

PMID:
22580673
[PubMed - indexed for MEDLINE]
17.

Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection.

Zhong C, Wei W, Su XK, Li HD, Xu FB, Guo RP.

Hepatogastroenterology. 2012 Jan-Feb;59(113):93-7. doi: 10.5754/hge10638.

PMID:
22251524
[PubMed - indexed for MEDLINE]
18.

Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis.

Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Pai JT, Loong CC, Chiou YY, Lee RC, Lee FY, Huo TI, Lee SD.

Ann Surg Oncol. 2012 Mar;19(3):842-9. doi: 10.1245/s10434-011-2060-1. Epub 2011 Sep 13.

PMID:
21913008
[PubMed - indexed for MEDLINE]
19.

Characteristics and surgical outcome of HCC patients with low platelet count.

Kondo K, Chijiiwa Y, Otani K, Kai M, Ohuchida J, Chijiiwa K.

Hepatogastroenterology. 2012 Oct;59(119):2269-72. doi: 10.5754/hge10649.

PMID:
23435142
[PubMed - indexed for MEDLINE]
20.

Hepatectomy with chemoembolization for treatment of hepatocellular carcinoma.

Ochiai T, Sonoyama T, Hironaka T, Yamagishi H.

Hepatogastroenterology. 2003 May-Jun;50(51):750-5.

PMID:
12828078
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk